HALO logo
halo search icon
Biodesix, Inc.

US$14.37

Price Change Indicator
0.43 (3.08%)
Biodesix, Inc.
BDSX · NAS

Biodesix, Inc.

Start Trading BDSX for Free

US$14.37

Price Arrow0.43 (3.08%)
20/05/2026 04:00:00 PM
All-CompaniesAll-ConsensusHALO AllHALO Consensus ValueHALO Price MomentumHammer Bearish
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Biodesix, Inc. Overview

BDSX Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Strong

Earnings

Very Weak

Growth

Earnings

Weak

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

About BDSX

icon
icon

Telephone

1.303.417.0500

icon

Address

919 West Dillon Road, Louisville, CO 80027

Description

Biodesix, Inc. provides blood-based diagnostics services for patients with lung disease. The firm offers GeneStrat, a genomic blood test for patients who have been diagnosed with advanced lung cancer and VeriStrat, a serum proteomic test that provides prognostic and predictive information for patients with non-small cell lung cancer. It also offers six diagnostic tests including: Nodify XL2, Nodify CDT, GeneStrat, VeriStrat, Bio-Rad SARS-CoV-2 ddPCR test and the Platelia SARS-CoV-2 test. The company was founded by David Brunel and Robert E. Cawthorn in 2005 and is headquartered in Louisville, CO.

BDSX Price Chart

Key Stats

Market Cap

US$140.91M

PE

0.00

EV/EBITDA

N/A

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 5 - 20.21

Trade Value (12mth)

US$1,105,119.00

1 week

-1.62%

1 month

8.48%

YTD

115.79%

1 year

76.41%

All time high

639.80

Key Fundamentals

EPS 3 yr Growth

-85.00%

EBITDA Margin

-25.00%

Operating Cashflow

-$23m

Free Cash Flow Return

-30.80%

ROIC

-46.70%

Interest Coverage

-2.90

Quick Ratio

1.80

Other Data

Shares Outstanding (Fully Diluted)

10m

HALO Sector

Healthcare

Next Company Report Date

16-Mar-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

BDSX Announcements

Latest Announcements

DateAnnouncements
21 May 26
21 May 26
05 May 26
05 May 26
05 May 26

BDSX Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
 $locklocklocklock-12.7-6.62-4.67locklocklock
EPS (Fully Diluted)
 $locklocklocklock-12.7-6.62-4.67locklocklock
Growth
 %locklocklocklock59.147.929.5locklocklock
PE
 XlocklocklocklockN/AN/AN/Alocklocklock
EV/EBITDA
 XlocklocklocklockN/AN/AN/Alocklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of Biodesix, Inc. (BDSX:NAS)?
Halo FAQ
The current share price of Biodesix, Inc. (BDSX:NAS) is USD$14.37.
What is the 52-week high share price for Biodesix, Inc. (BDSX:NAS)?
Halo FAQ
The 52-week high share price for Biodesix, Inc. (BDSX:NAS) is USD$20.21.
What is the 52-week low share price for Biodesix, Inc. (BDSX:NAS)?
Halo FAQ
The 52-week low share price for Biodesix, Inc. (BDSX:NAS) is USD$5.00.
What is the dividend yield for Biodesix, Inc. (BDSX:NAS)?
Halo FAQ
Biodesix, Inc. (BDSX:NAS) does not pay a dividend.
What was Biodesix, Inc. (BDSX:NAS) last dividend payment?
Halo FAQ
Biodesix, Inc. (BDSX:NAS) does not pay a dividend.
What is the franking level for Biodesix, Inc. (BDSX:NAS)?
Halo FAQ
Biodesix, Inc. (BDSX:NAS) has a franking level of 0.00%.
In which sector is Biodesix, Inc. (BDSX:NAS) classified?
Halo FAQ
Biodesix, Inc. (BDSX:NAS) is classified in the Healthcare.

See beyond the curve.

One solution for research, investing and portfolio management.
Start FREE Trial